VANGUARD GROUP INC - BALCHEM CORP ownership

BALCHEM CORP's ticker is BCPC and the CUSIP is 057665200. A total of 287 filers reported holding BALCHEM CORP in Q3 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.2%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of BALCHEM CORP
ValueSharesWeighting
Q3 2023$466,470,282
-8.1%
3,760,644
-0.1%
0.01%
-8.3%
Q2 2023$507,624,359
+5.1%
3,765,480
-1.4%
0.01%0.0%
Q1 2023$482,922,647
+3.0%
3,818,174
-0.6%
0.01%
-7.7%
Q4 2022$469,081,658
-0.1%
3,841,468
-0.5%
0.01%
-7.1%
Q3 2022$469,545,000
+0.5%
3,862,027
+7.3%
0.01%
+7.7%
Q2 2022$467,128,000
-3.0%
3,600,493
+2.2%
0.01%
+18.2%
Q1 2022$481,537,000
-23.7%
3,522,583
-5.9%
0.01%
-21.4%
Q4 2021$631,379,000
+17.1%
3,744,839
+0.8%
0.01%
+7.7%
Q3 2021$538,977,000
+10.9%
3,715,290
+0.3%
0.01%
+8.3%
Q2 2021$486,190,000
+5.9%
3,704,024
+1.1%
0.01%0.0%
Q1 2021$459,308,000
+11.1%
3,662,445
+2.0%
0.01%0.0%
Q4 2020$413,539,000
+20.8%
3,589,118
+2.4%
0.01%
+9.1%
Q3 2020$342,315,000
-0.6%
3,506,251
-3.4%
0.01%
-8.3%
Q2 2020$344,315,000
-6.7%
3,629,719
-3.0%
0.01%
-25.0%
Q1 2020$369,233,000
-0.6%
3,740,205
+2.3%
0.02%
+23.1%
Q4 2019$371,627,000
+2.0%
3,656,656
-0.4%
0.01%
-7.1%
Q3 2019$364,238,000
+0.4%
3,672,118
+1.2%
0.01%0.0%
Q2 2019$362,757,000
+7.9%
3,628,666
+0.1%
0.01%
+7.7%
Q1 2019$336,345,000
+30.3%
3,624,394
+10.0%
0.01%
+8.3%
Q4 2018$258,191,000
-29.2%
3,295,361
+1.3%
0.01%
-14.3%
Q3 2018$364,622,000
+17.1%
3,252,944
+2.6%
0.01%
+7.7%
Q2 2018$311,283,000
+23.2%
3,171,825
+2.7%
0.01%
+18.2%
Q1 2018$252,564,000
+5.4%
3,089,466
+4.0%
0.01%
+10.0%
Q4 2017$239,541,000
+0.1%
2,971,978
+0.9%
0.01%
-9.1%
Q3 2017$239,372,000
+6.8%
2,944,666
+2.1%
0.01%0.0%
Q2 2017$224,210,000
-4.4%
2,885,217
+1.4%
0.01%
-8.3%
Q1 2017$234,502,000
+3.5%
2,845,201
+5.4%
0.01%
-7.7%
Q4 2016$226,560,000
+12.2%
2,699,711
+3.6%
0.01%
+8.3%
Q3 2016$201,947,000
+33.9%
2,604,750
+3.0%
0.01%
+33.3%
Q2 2016$150,866,000
-1.7%
2,529,184
+2.2%
0.01%
-10.0%
Q1 2016$153,476,000
+5.4%
2,474,626
+3.3%
0.01%0.0%
Q4 2015$145,649,000
-77.1%
2,395,530
-82.7%
0.01%
-58.3%
Q3 2015$635,852,000
+407.1%
13,825,739
+514.3%
0.02%
+200.0%
Q2 2015$125,397,000
+4.1%
2,250,482
+3.5%
0.01%0.0%
Q1 2015$120,428,000
-13.1%
2,174,580
+4.6%
0.01%
-20.0%
Q4 2014$138,598,000
+18.8%
2,079,809
+0.9%
0.01%
+11.1%
Q3 2014$116,649,000
+6.5%
2,062,031
+0.8%
0.01%0.0%
Q2 2014$109,522,000
+3.1%
2,044,844
+0.3%
0.01%0.0%
Q1 2014$106,277,000
-7.2%
2,039,069
+4.5%
0.01%
-10.0%
Q4 2013$114,487,000
+19.0%
1,950,379
+4.9%
0.01%
+11.1%
Q3 2013$96,239,000
+19.2%
1,859,681
+3.1%
0.01%
+12.5%
Q2 2013$80,746,0001,804,3850.01%
Other shareholders
BALCHEM CORP shareholders Q3 2023
NameSharesValueWeighting ↓
SANTA MONICA PARTNERS LP 353,431$59,588,00037.96%
Conestoga Capital Advisors, LLC 1,000,708$168,719,0002.20%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 71,969$12,134,0001.86%
Tributary Capital Management, LLC 140,224$23,642,0001.78%
GENEVA CAPITAL MANAGEMENT LLC 651,326$109,813,0001.77%
Cutter & CO Brokerage, Inc. 33,549$5,656,0001.55%
WASATCH ADVISORS LP 1,693,842$285,582,0001.16%
MOODY ALDRICH PARTNERS LLC 49,518$8,349,0001.16%
ICW Investment Advisors LLC 10,875$1,834,0001.02%
Kensington Investment Counsel, LLC 9,074$1,530,0000.89%
View complete list of BALCHEM CORP shareholders